You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Boehringer Ingelheim
Moodys
McKinsey
AstraZeneca

Last Updated: June 7, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METHYLPHENIDATE HYDROCHLORIDE

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Methylphenidate Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000268 Cocaine Abuse and Attention Deficit Disorder - 3 Completed New York State Psychiatric Institute N/A 1995-05-01 The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
NCT00000268 Cocaine Abuse and Attention Deficit Disorder - 3 Completed National Institute on Drug Abuse (NIDA) N/A 1995-05-01 The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
NCT00003266 Methylphenidate in Treating Patients With Melanoma Completed National Cancer Institute (NCI) Phase 3 1999-06-01 RATIONALE: Methylphenidate may relieve some of the side effects of chemotherapy in patients with melanoma. It is not known whether receiving methylphenidate is more effective than receiving no further therapy in treating patients with melanoma. PURPOSE: Randomized phase III trial to determine if methylphenidate is more effective than no further therapy for the relief of fatigue and drowsiness in treating patients with melanoma who have received high-dose interferon alfa for 8-24 weeks.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Methylphenidate Hydrochloride

Condition Name

Condition Name for Methylphenidate Hydrochloride
Intervention Trials
Attention Deficit Hyperactivity Disorder 95
Attention Deficit Disorder With Hyperactivity 44
ADHD 41
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Methylphenidate Hydrochloride
Intervention Trials
Attention Deficit Disorder with Hyperactivity 206
Hyperkinesis 143
Disease 84
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Methylphenidate Hydrochloride

Trials by Country

Trials by Country for Methylphenidate Hydrochloride
Location Trials
United States 603
Canada 36
Israel 24
Germany 21
France 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Methylphenidate Hydrochloride
Location Trials
California 46
Massachusetts 40
New York 39
Texas 38
Ohio 38
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Methylphenidate Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Methylphenidate Hydrochloride
Clinical Trial Phase Trials
Phase 4 128
Phase 3 81
Phase 2/Phase 3 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Methylphenidate Hydrochloride
Clinical Trial Phase Trials
Completed 209
Recruiting 64
Not yet recruiting 33
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Methylphenidate Hydrochloride

Sponsor Name

Sponsor Name for Methylphenidate Hydrochloride
Sponsor Trials
Massachusetts General Hospital 28
National Institute of Mental Health (NIMH) 27
National Institute on Drug Abuse (NIDA) 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Methylphenidate Hydrochloride
Sponsor Trials
Other 369
Industry 134
NIH 72
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
AstraZeneca
Merck
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.